Serological testing plays a pivotal role in understanding pre-existing immunity, infection and immunogenicity. However, conventional characterization assays often pose challenges in terms of complexity, time consumption and resource requirements, particularly when assessing antibody titers against multiple targets.
InDevR’s VaxArray® Platform addresses these logistical hurdles by simplifying and streamlining analytical development through its innovative, multiplexed microarray-based technology. This technology enables the generation of multiple results from a single test for high-value applicability to multivalent vaccines.
The VaxArray Platform comprises a versatile range of applications in serology and vaccine analytics, encompassing serum antibody quantification, identity testing, antigen quantification, characterization of nucleic acid vaccine constructs and assessment of cell-based potency assays for mRNA vaccines. InDevR’s off-the-shelf, multiplexed kits, alongside user-friendly instrumentation and data analysis tools, facilitate rapid sample processing with a typical turnaround time of less than 90 minutes.
In this webinar, the expert speaker will showcase the utility of the VaxArray Platform in serological testing, emphasizing its distinctive advantages in this field compared to traditional approaches. They will also focus on off-the-shelf kits tailored for COVID serological testing and serological applications for pneumococcal conjugate vaccines, in addition to a review of corresponding data. Additionally, the speaker will discuss about custom kit development for serological testing, including specific examples of custom serology projects.
Register for this webinar today to gain insights into the transformative capabilities of an innovative, multiplexed microarray-based technology for serological testing and vaccine analytics.
Speaker
April Ruka, PhD, Application Scientist, InDevR
April Ruka, PhD, is a native of New Orleans and completed her undergraduate studies in Chemical and Biomolecular Engineering at Tulane University before obtaining her PhD in Bioengineering from Georgia Tech. As a member of InDevR’s Application Scientists’ team, Dr. Ruka focuses on advancing the implementation of multiplex immunoassays in vaccine and biotherapeutics production.
Message PresenterWho Should Attend?
This webinar will appeal to the professionals with the following titles or those working in the following fields:
- R&D Scientists
- Production Scientists
- Lab Managers/Technology Transfer Managers
- Quality Control Specialists
- CROs/CMOs
- Regulatory affairs
- Biotech/Pharmaceutical companies
- Private research organizations/Academic researchers
- Government representatives
What You Will Learn
Attendees will learn about:
- How to utilize the VaxArray Platform for serological testing and its key advantages over traditional approaches, including sample processing that delivers multiple results in a single test in as little as 30 minutes
- How the simple-to-use VaxArray Platform provides a streamlined path to validated analytical assays with faster, more reliable results
- Obtaining real-world data for serological applications and testing using InDevR’s off-the-shelf, pre-validated kits
- The capabilities and processes for custom kit development for serological applications and testing with specific project examples
Xtalks Partner
InDevR
InDevR is a leader in innovative technologies for vaccine testing and multiplexed assay development. Committed to enhancing the speed and accuracy of vaccine characterization, InDevR’s products and services are trusted by leading pharmaceutical companies and research institutions around the globe.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account